Product Code: 26712
KEY FINDINGS
The global bone densitometer market growth is anticipated to progress at a CAGR of 4.30% during the forecast period, 2022-2030. The market growth is attributed to technological advancements like DXA scanners, the rising degenerative joint diseases, the increasing prevalence of osteoporosis, and the growing geriatric population.
MARKET INSIGHTS
A bone densitometer is an advanced form of X-ray technology that can determine osteoporosis and measure bone loss. The geriatric population is on the surge worldwide. Given the advancing medical science, the death, infections, and disease rates have decreased with life expectancy increasing. The aging population faces problems like dementia, depression, diabetes, malnutrition, decreased bone density due to low calcium, etc. In addition, the weaker bones result in the old age population witnessing several types of bone-related problems like Paget's disease, gout, and rheumatoid arthritis. Besides, the population of older people is set to grow by 14%, as per the World Population Prospects in 2040. Such aspects drive the global bone densitometer market demands. However, the market growth is hindered by high costs and a lack of awareness.
REGIONAL INSIGHTS
The global bone densitometer market growth assessment includes the evaluation of Asia-Pacific, Europe, North America, and Rest of World. North America is the major region, with regard to the largest revenue share, attributed to world-class healthcare systems and advanced technologies.
COMPETITIVE INSIGHTS
The market is fragmented, with several international and domestic companies operating the market. As a result, the competitive rivalry is estimated to be high. Some of the eminent firms operating in the market include Echolight Spa, Eurotec Systems Srl, BeamMed Ltd, Diagnostic Medical Systems Group, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
- 1.1. STUDY OBJECTIVES
- 1.2. SCOPE OF STUDY
- 1.3. METHODOLOGY
- 1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
- 2.1. MARKET SIZE & ESTIMATES
- 2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
- 3.1. KEY DRIVERS
- 3.1.1. RISING GERIATRIC POPULATION
- 3.1.2. GROWING PREVALENCE OF OSTEOPOROSIS
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS LIKE DXA SCANNERS
- 3.1.4. INCREASING DEGENERATIVE JOINT DISEASES
- 3.2. KEY RESTRAINTS
- 3.2.1. HIGH COST OF BONE DENSITOMETERS
- 3.2.2. LACK OF PUBLIC AWARENESS
- 3.2.3. RISK FACTORS OF BONE DENSITOMETER
4. KEY ANALYTICS
- 4.1. IMPACT OF COVID-19 ON BONE DENSITOMETER MARKET
- 4.2. KEY MARKET TRENDS
- 4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
- 4.4. OPPORTUNITY MATRIX
- 4.5. VENDOR LANDSCAPE
- 4.6. VALUE CHAIN ANALYSIS
5. MARKET BY TECHNOLOGY
- 5.1. AXIAL BONE DENSITOMETRY
- 5.1.1. DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA)
- 5.1.2. QUANTITATIVE COMPUTED TOMOGRAPHY (QCT)
- 5.2. PERIPHERAL BONE DENSITOMETRY
- 5.2.1. PERIPHERAL DUAL ENERGY X-RAY ABSORPTIOMETRY (PDEXA)
- 5.2.2. ULTRASOUND
- 5.2.3. OTHER TECHNOLOGIES
6. MARKET BY END-USER
- 6.1. HOSPITALS
- 6.2. SPECIALTY CLINICS
- 6.3. OTHER END-USERS
7. MARKET BY APPLICATION
- 7.1. OSTEOPOROSIS AND OSTEOPENIA
- 7.2. CYSTIC FIBROSIS
- 7.3. RHEUMATOID ARTHRITIS
- 7.4. BODY COMPOSITION MEASUREMENT
8. GEOGRAPHICAL ANALYSIS
- 8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
- 8.1.5.1. UNITED STATES
- 8.1.5.2. CANADA
- 8.2. EUROPE
- 8.2.1. MARKET SIZE & ESTIMATES
- 8.2.2. KEY GROWTH ENABLERS
- 8.2.3. KEY CHALLENGES
- 8.2.4. KEY PLAYERS
- 8.2.5. COUNTRY ANALYSIS
- 8.2.5.1. UNITED KINGDOM
- 8.2.5.2. GERMANY
- 8.2.5.3. FRANCE
- 8.2.5.4. SPAIN
- 8.2.5.5. ITALY
- 8.2.5.6. NORDIC COUNTRIES
- 8.2.5.7. REST OF EUROPE
- 8.3. ASIA-PACIFIC
- 8.3.1. MARKET SIZE & ESTIMATES
- 8.3.2. KEY GROWTH ENABLERS
- 8.3.3. KEY CHALLENGES
- 8.3.4. KEY PLAYERS
- 8.3.5. COUNTRY ANALYSIS
- 8.3.5.1. CHINA
- 8.3.5.2. JAPAN
- 8.3.5.3. INDIA
- 8.3.5.4. SOUTH KOREA
- 8.3.5.5. INDONESIA
- 8.3.5.6. SINGAPORE
- 8.3.5.7. AUSTRALIA & NEW ZEALAND
- 8.3.5.8. REST OF ASIA-PACIFIC
- 8.4. REST OF WORLD
- 8.4.1. MARKET SIZE & ESTIMATES
- 8.4.2. KEY GROWTH ENABLERS
- 8.4.3. KEY CHALLENGES
- 8.4.4. KEY PLAYERS
- 8.4.5. REGIONAL ANALYSIS
- 8.4.5.1. LATIN AMERICA
- 8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
- 9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PARTNERSHIPS & AGREEMENTS
- 9.2. COMPANY PROFILES
- 9.2.1. BEAMMED LTD
- 9.2.2. DIAGNOSTIC MEDICAL SYSTEMS GROUP
- 9.2.3. ECHOLIGHT SPA
- 9.2.4. EUROTEC SYSTEMS SRL
- 9.2.5. GE HEALTHCARE
- 9.2.6. HOLOGIC INC
- 9.2.7. L'ACN L'ACCESSORIO NUCLEARE SRL
- 9.2.8. MEDILINK
- 9.2.9. MEDONICA CO LTD
- 9.2.10. OSCARE MEDICAL OY
- 9.2.11. OSI SYSTEMS INC
- 9.2.12. OSTEOMETER MEDITECH INC
- 9.2.13. SCANFLEX HEALTHCARE AB
- 9.2.14. SWISSRAY GLOBAL HEALTHCARE HOLDING LTD
- 9.2.15. TRIVITRON HEALTHCARE